WELLINGTON MANAGEMENT GROUP LLP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$471,552
-42.3%
312,286
-4.4%
0.00%
Q4 2022$816,635
-41.9%
326,654
-1.9%
0.00%
Q3 2022$1,405,000
+18.9%
332,911
-21.4%
0.00%
Q2 2022$1,182,000
-88.1%
423,593
-75.5%
0.00%
-100.0%
Q1 2022$9,894,000
-33.9%
1,729,772
+5.6%
0.00%0.0%
Q4 2021$14,957,000
-42.2%
1,638,273
-32.4%
0.00%
-50.0%
Q3 2021$25,895,000
-60.5%
2,422,422
-42.6%
0.00%
-63.6%
Q2 2021$65,521,000
-30.9%
4,221,689
-27.8%
0.01%
-35.3%
Q1 2021$94,785,000
-35.4%
5,847,348
-15.7%
0.02%
-37.0%
Q4 2020$146,798,000
+174.1%
6,935,914
+92.0%
0.03%
+145.5%
Q3 2020$53,550,000
+16.5%
3,613,296
+15.6%
0.01%
+10.0%
Q2 2020$45,970,000
+60.5%
3,125,095
+28.1%
0.01%
+25.0%
Q1 2020$28,647,000
-72.9%
2,439,996
-45.8%
0.01%
-63.6%
Q4 2019$105,699,000
+30.2%
4,497,829
+2.5%
0.02%
+22.2%
Q3 2019$81,207,000
-9.0%
4,389,517
-8.5%
0.02%
-10.0%
Q2 2019$89,191,000
-29.1%
4,797,738
-6.7%
0.02%
-28.6%
Q1 2019$125,744,000
+5.9%
5,144,988
+12.4%
0.03%
-6.7%
Q4 2018$118,750,000
-18.7%
4,577,871
-0.8%
0.03%
-3.2%
Q3 2018$146,011,000
-21.2%
4,613,317
-3.3%
0.03%
-24.4%
Q2 2018$185,321,000
+209.0%
4,770,175
+119.5%
0.04%
+192.9%
Q1 2018$59,974,0002,172,9460.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders